A global health company is seeking novel therapeutics for chronic and situational anxiety. Specifically, our client is interested in novel treatments with rapid onset that can be administered either daily (with a target of 4-6 hours of efficacy) for situational anxiety, or as a long-acting treatment (preferably monthly treatment) for chronic anxiety.
Therapeutics should have minimal side effects such as gastrointestinal issues, sedation, ataxia, and lethargy. Safety and efficacy studies in rodents, dogs and cats are preferred.
Approaches of Interest:
Biotech Asset
Spinout Company
Research Project
Technology
Biotech Asset
Spinout Company
Research Project
Technology
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.